Huntington disease

267,861views

Huntington disease

Fysio Review

Fysio Review

Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Glycolysis
Liver anatomy and physiology
Body temperature regulation (thermoregulation)
Olfactory transduction and pathways
Neuromuscular junction and motor unit
Anatomy and physiology of the eye
Photoreception
Blood pressure, blood flow, and resistance
Microcirculation and Starling forces
Neuron action potential
Menopause
Progestins and antiprogestins
Estrogens and antiestrogens
Renin-angiotensin-aldosterone system
Baroreceptors
Chemoreceptors
Cardiac conduction system
ECG basics
Pressures in the cardiovascular system
Resistance to blood flow
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Physiological changes during exercise
Excitability and refractory periods
Action potentials in myocytes
Action potentials in pacemaker cells
ECG normal sinus rhythm
Endocrine system anatomy and physiology
Hunger and satiety
Adrenocorticotropic hormone
Oxytocin and prolactin
Antidiuretic hormone
Thyroid hormones
Insulin
Cortisol
Estrogen and progesterone
Testosterone
Parathyroid hormone
Phosphate, calcium and magnesium homeostasis
Calcitonin
Vitamin D
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibulo-ocular reflex and nystagmus
Taste and the tongue
Gastrointestinal system anatomy and physiology
Enteric nervous system
Gastric motility
Chewing and swallowing
Carbohydrates and sugars
Fats and lipids
Proteins
Pancreatic secretion
Bile secretion and enterohepatic circulation
Blood components
Erythropoietin
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Complement system
Innate immune system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Cell-mediated immunity of CD4 cells
Antibody classes
Somatic hypermutation and affinity maturation
B- and T-cell memory
Bone remodeling and repair
Muscular system anatomy and physiology
Slow twitch and fast twitch muscle fibers
Muscle contraction
Nervous system anatomy and physiology
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Muscle spindles and golgi tendon organs
Somatosensory receptors
Somatosensory pathways
Sympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Parasympathetic nervous system
Basal ganglia: Direct and indirect pathway of movement
Memory
Sleep
Learning
Body fluid compartments
Movement of water between body compartments
Hydration
Glomerular filtration
Regulation of renal blood flow
Urea recycling
Tubular reabsorption of glucose
Tubular reabsorption and secretion of weak acids and bases
Proximal convoluted tubule
Loop of Henle
Distal convoluted tubule
Sodium homeostasis
Osmoregulation
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Acid-base map and compensatory mechanisms
Respiratory acidosis
Metabolic acidosis
Plasma anion gap
Respiratory alkalosis
Metabolic alkalosis
Puberty and Tanner staging
Anatomy and physiology of the female reproductive system
Anatomy and physiology of the male reproductive system
Pregnancy
Respiratory system anatomy and physiology
Lung volumes and capacities
Alveolar surface tension and surfactant
Ventilation
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Pulmonary chemoreceptors and mechanoreceptors
Breathing control
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Parkinson disease
Anti-parkinson medications
Restrictive lung diseases
Arterial disease
Huntington disease
Introduction to pharmacology
Pharmacokinetics: Drug metabolism
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Alpha blockers
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Hypoglycemics: Insulin secretagogues
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Hyperthyroidism medications
Acid reducing medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Glucocorticoids
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Medications for neurodegenerative diseases
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
Androgens and antiandrogens
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Alcohol use disorder
Substance misuse and addiction: Clinical
Gluconeogenesis
Hypertension: Clinical
Tobacco use disorder
Anemia: Clinical
Metabolic and respiratory acidosis: Clinical
Breathing cycle and regulation
Bipolar and related disorders
Schizophrenia
Amnesia
Attention deficit hyperactivity disorder
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Hypertension
Dyslipidemias: Pathology review
Ischemic stroke

Transcript

Watch video only

Huntington disease, or HD, is a rare neurodegenerative disease that involves a repeated sequence of DNA that causes an abnormal protein to form, leading to abnormal movements and cognitive problems.

Huntington disease is an autosomal dominant genetic disorder, which means that one affected copy of a gene is enough to cause disease. Affected people are typically present in each generation, because an affected person (male or female) has a 50% chance of passing on the affected gene to a child, which causes that child to have the disease.

In most people, a gene called huntingtin or HTT on chromosome 4, contains a triplet repeat, where the nucleotides C, A, and G are repeated 10-35 times in a row. In people with Huntington disease, this repeat goes on for 36 or more times in a row. CAG codes for the amino acid glutamine, so people with Huntington disease patients will have 36 or more glutamines in a row in the huntingtin protein. So, in addition to being a triplet repeat disorder, HD is, more specifically, a “polyglutamine” disease.

The specific way in which extra glutamines cause HD symptoms isn’t fully worked out, but some clues are that the mutated protein aggregates within the neuronal cells of the caudate and putamen of the basal ganglia causing neuronal cell death. Cell death might be related to excitotoxicity – which is excessive signaling of these neurons, which leads to high intracellular calcium.

The expanded CAG repeats not only affect the huntingtin protein – they affect DNA replication itself. When copying the HTT gene, DNA polymerase can basically lose track of which CAG it’s on and accidently add extra CAGs. Since as a zygote develops into a fetus and eventually into a full adult, by the time sperm and eggs are created, several dozen cell divisions, each with a round of DNA replication have taken place, and so there have already been ample opportunities for repeat expansion, and the more repeats that’re added, the more unstable it gets.

This expansion of the originally inherited gene means a child of a parent with HD can inherit even more CAG repeats than the parent did. The higher the number of repeats in the protein, the earlier the age when a person starts having symptoms. This phenomenon is called anticipation, which means that Huntington disease families often show earlier symptom onset with each generation. Even repeats of 27-35 CAGs can expand occasionally; these are called “pre-mutation” alleles, since they don’t cause the disease, but they’re set-up for developing a mutation of 36 or more CAGs.

This process of adding more repeats is called repeat expansion and it happens way more in the production of sperm than of eggs, so both anticipation and new disease alleles generally happens when the father is the affected parent. When a person has 40+ repeats, they show 100% penetrance and they will have the disease. For reasons that remain unknown, people with 36-39 repeats can show reduced penetrance; some may have symptoms while others may not. Because of this penetrance, the test for HD, which counts the number of CAG repeats, is really good at determining whether HD will develop in an at-risk individual.